ARTICLE | Company News
Biofrontera, Switch Biotech deal
September 19, 2005 7:00 AM UTC
Biofrontera acquired from Switch an undisclosed compound to treat dermatological indications. Biofrontera, which will develop the compound for atopic dermatitis, said the compound is marketed for indi...